Atossa Therapeutics, Inc.

Ownership Transactions Reported by 10 Insiders

Symbol: ATOS on Nasdaq
Industry: Pharmaceutical Preparations
Location: 10202 5 Th Avenue Ne, Suite 200, Seattle, Washington

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+25K	33.3%	$1.77	+$44.3K
Sells	1	-50K	66.7%	$0.65	-$32.5K
Net	0	-25K	-33.3%		+$11.8K

Atossa Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Jonathan Finn	Director	$44.3K	+$44.3K		Jun 27, 2024
Gregory L. Weaver	Former EVP, CFO, & Director, Director	$36.00	-$32.5K	-99.9%	Nov 15, 2023
Richard Steinhart	Director				Jun 27, 2024
H. Lawrence Remmel	Director				Jun 27, 2024
Stephen J. Galli	Director				Jun 27, 2024
Shu-Chih Chen	Director				Jun 27, 2024
Kyle Guse	CFO, Gen Counsel and Secretary				Mar 2, 2023
Tessa Cigler	Director				Jun 27, 2024
Heather Rees	SVP, Finance and Accounting				Jun 27, 2024
Steven C. Quay	President & CEO, Director				Jun 27, 2024

Recent Insider Transactions by Companies or Individuals for Atossa Therapeutics, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.